Clinical study to evaluate the efficacy and safety of diclofenac potassium 25 mg tablets in subjects with acute joint pain Klinische Prüfung zur Bewertung der Wirksamkeit und Sicherheit von Diclofenac-Kalium 25 mg Tabletten bei Probanden mit akuten Gelenkschmerzen To evaluate the efficacy of diclofenac potassium 25 mg tablet taken 3 times a day compared with placebo in subjects with acute ankle sprains under ‘in-use’ conditions, in particular with regard to pai...

• Country None
• organs None
• Specialty None

Arginine supplementation in severe sepsis: effects on metabolism and microcirculation Not provided at time of registration

• Country Netherlands
• organs None
• Specialty None

Study to evaluate the safety and effects of Voltaren Schmerzgel 1.16% on people with acute neck pain To show superior efficacy of Voltaren® Schmerzgel 1.16% gel versus placebo in the treatment of acute neck pain under 'in-use' conditions, as measured by POM at Visit 4.

• Country None
• organs None
• Specialty None

A randomized, double-blind, multi-center, placebo-controlled, parallel group study to evaluate the efficacy and safety of diclofenac sodium topical gel 1% applied four times daily in subjects with acute ankle sprain To evaluate the efficacy of DSG 1% applied four times a day compared with placebo in subjects with acute ankle sprains under ‘in-use’ conditions, in particular with regard to pain relief.

• Country None
• organs None
• Specialty None

A randomized, double-blind, parallel group, single-dose study of the efficacy of lidocaine 8 mg + cetylpyridinium chloride (CPC) 2 mg fixed combination lozenges on sore throat pain intensity compared to Mebucaine CL lozenges (containing lidocaine 1 mg and CPC 2 mg) in subjects with sore throat due to upper respiratory tract infection The main purpose of this trial is to compare the efficacy and safety of a single dose of a lidocaine 8 mg + 2 mg cetylpyridinium (CPC) lozenge with a single dose of a Mebucaine CL lozenge (containing ...

• Country None
• organs None
• Specialty None

Clinical study to evaluate the efficacy and safety of diclofenac diethylamine 2.32% gel in subjects with knee osteoarthritis The primary objective of the study is to evaluate the efficacy of DDEA 2.32% gel b.i.d. vs. vehicle on POM after 2 weeks of treatment in patients suffering from knee OA.

• Country None
• organs None
• Specialty None

A randomized, double-blind, multi-center, placebo-controlled, 3-treatment arm, parallel group study to evaluate the efficacy and safety of diclofenac diethylamine 2.32% gel applied twice or three times daily in patients with acute ankle sprain To evaluate the efficacy of diclofenac diethylamine (DDEA) 2.32% twice or three times a day in patients with acute ankle sprains under "in-use" conditions, in particular with regard to pain relief aft...

• Country None
• organs None
• Specialty None

An 8-week, multi-center, randomized, double-blind, placebo-controlled, parallel group trial of Diclofenac Sodium Gel 1% in patients with primary osteoarthritis of the hand To compare the efficacy of DSG 1%, applied four times a day vs. placebo in OA of the hand, based on assessment of three efficacy outcomes, each assessed on a 100 mm VAS, at Week 4 and Week 6: - OA ...

• Country None
• organs None
• Specialty None

A randomized, double-blind, multi-center, placebo-controlled, parallel group study to evaluate the efficacy and safety of diclofenac sodium topical gel 1% applied four times daily in subjects with acute blunt soft tissue injuries/contusions of the limbs To evaluate the efficacy of Diclofenac sodium topical gel (DSG) 1% applied four times a day compared with placebo in subjects with acute blunt, soft tissue injuries/contusions of the limbs.

• Country None
• organs None
• Specialty None

A randomized, double-blind, multi-center, vehicle-controlled, parallel group study to evaluate the efficacy and safety of diclofenac diethylamine 2.32% gel applied once or twice daily in subjects with acute ankle sprain to evaluate the efficacy of DDEA 2.32% gel administered OD or BID for 4 days compared with vehicle/placebo for the treatment of acute ankle sprain

• Country None
• organs None
• Specialty None